In recent years, the pharmaceutical business has faced unprecedented challenges. The US has seen a 24% increase in the average cost of pharmaceuticals over the last three years as a result of safety concerns, issues with certain prescriptions, and competition from both non-generic and generic medications. This resulted in a 4% drop in prescription expenses for those with private insurance between 2010 and 2013.Growing markets like China, India, and Brazil have similar problems. Creating a variety of vaccines with therapeutic benefits is one possible remedy.In order to treat bacterial illnesses and maintain population and individual health over the long term, antibiotics are required. Antibiotic-resistant bacterial diseases, however, pose a threat to international health.